Tsujino Ichiro

ツジノイチロウ | Tsujino Ichiro

Affiliation and department：
Job title： Associate Professor
Other affiliations (2)：

Research field (4)： Cell biology , Tumor biology , Respiratory medicine , Medical biochemistry

Research keywords (7)： pERK(ERK1/2) , がん微小環境/細胞内酸性化/高温感受性 , 標的分子と分子標的薬 , pERK , がん微小環境 , 薬剤耐性 , 抗がん剤

Papers (24)：

Tanaka S, Kushimoto M, Nishizawa T, Takubo M, Mitsuke K, Ikeda J, Fujishiro M, Ogawa K, Tsujino I, Suzuki Y, et al. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report. Clin Diabetes Endocrinol. 2020. JAN. 6. 1-6
Ichiro Tsujino, Ryoko Ushikoshi_Nakayama, Tomoe Yamazaki, Naoyuki Matsumoto, Ichiro Saito. Pulmonary activation of vitamin D and preventive effect against interstitial pneumonia. Journal of Clinical Biochemistry and Nutrition. 2019. 65. 3. 245-251
Shimizu T, Nakagawa Y, Asai Y, Tsujino I, Takahashi N, Gon Y. A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer. .J Int Med Res. 2019. 47. 7. 3079-3087
Nakanishi Y, Nakagawa Y, Tsujino I, Shimizu T, Takahashi N, Hashimoto S, Masuda S. Favorable Outcome With Pemetrexed Treatment for Advanced BRAF-V600E-Positive Lung Adenocarcinoma in a Patient Followed up Over 8 Years. Journal of Thoracic Oncology. 2018. 13. 10. e199-e202
永田弥人, 赤羽目翔悟, 西澤司, 蓮見禎行, 辻野一郎, 小川克彦, 鈴木裕, 橋本修, 相馬正義. 肺線維症による縦隔気腫と気腹症の1例. 日大医学雑誌. 2018. 77. 3. 185-188

ｍore...

MISC (8)：

ｍore...

Lectures and oral presentations (14)：

肺がんの遺伝子検査における呼吸器細胞診検体の液状化処理の有用性(ミニシンポジウム: 肺癌治療1).
(第56回日本呼吸器学会学術講演会、京都、 2016)
MAPK (ERK1/2) activity due to driver mutations and prognosis in non-small-cell lung cancer.
(18th Congress of the Asian Pacific Society of Respirology (APSR), Yokohama, Japan, 2013)
Rapid and Simple Method for Detection EGFR Gene Mutation by Using Tm Analysis With Quenching Probes to Determine EGFR-TKI Treatment in Lung Adenocarcinoma.
(22nd Biennial Congress of the European Association for Cancer Research, Barcelona, Spain, 2012)
Correlation between differences in the increase in MAPK (ERK1/2) activity due to driver mutations and prognosis in non-small-cell lung cancer.
(22nd Biennial Congress of the European Association for Cancer Research, Barcelona, Spain, 2012)
Thymidylate Synthetase mRNA Expression in Lung Cancer Patients Treated with Pemetrexed. 14th World Conference on Lung Cancer, Amsterdam, Netherland, 2011, 7.
(4th World Conference on Lung Cancer, Amsterdam, Netherland, 2011)

ｍore...

Education (1)：

Professional career (2)：

Awards (3)：

2019/10/16 - 厚生労働大臣厚生労働大臣賞社会保険診療報酬支払基金関係功績者厚生労働大臣表彰
2018/05/19 - 日本大学医師会日本大学医学部・日本大学医師会学術奨励賞非小細胞肺癌におけるMAP kinase 活性度と治療効果および予後の検討 (特別講演)
1999/07/13 - American Society for Photobiology Travel Award for research presentation Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.

Association Membership(s) (4)：

日本肺癌学会 , 日本内科学会 , 日本呼吸器学会 , 日本呼吸器内視鏡学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page